83 related articles for article (PubMed ID: 3652051)
21. A study of the cytotoxicity of malignant pleural effusion lymphocytes and LAK cells against autologous tumor cells.
Guo YS; Xing ZL
Chin Med J (Engl); 1994 Dec; 107(12):903-5. PubMed ID: 7882727
[TBL] [Abstract][Full Text] [Related]
22. Up-regulation of tumor interleukin-8 expression by infiltrating macrophages: its correlation with tumor angiogenesis and patient survival in non-small cell lung cancer.
Chen JJ; Yao PL; Yuan A; Hong TM; Shun CT; Kuo ML; Lee YC; Yang PC
Clin Cancer Res; 2003 Feb; 9(2):729-37. PubMed ID: 12576442
[TBL] [Abstract][Full Text] [Related]
23. [Influence of tumor-associated macrophages on progression and prognosis of nasopharyngeal carcinoma].
Peng J; Ding T; Zheng LM; Shao JY
Ai Zheng; 2006 Nov; 25(11):1340-5. PubMed ID: 17094898
[TBL] [Abstract][Full Text] [Related]
24. Involvement of the omental lymphoid organ in the induction of peritoneal immunity against tumor cells.
Dullens HF; Rademakers LH; Doffemont M; Van Veen PT; Bulder R; Den Otter W
Invasion Metastasis; 1993; 13(5):267-76. PubMed ID: 7960579
[TBL] [Abstract][Full Text] [Related]
25. Glucan stimulates production of antitumor cytolytic/cytostatic factor(s) by macrophages.
Sherwood ER; Williams DL; Di Luzio NR
J Biol Response Mod; 1986 Dec; 5(6):504-26. PubMed ID: 3794756
[TBL] [Abstract][Full Text] [Related]
26. [An experimental model of pleural adenocarcinoma constructed by the implantation of intact human neoplastic tissue in the nude mouse. The prognostic value of a lesion of the visceral pleura].
Astoul P; Boutin C; Hoffman RM
Rev Mal Respir; 1995; 12(3):267-73. PubMed ID: 7638423
[TBL] [Abstract][Full Text] [Related]
27. Subcategorization of lung cancer based on tumor size and degree of visceral pleural invasion.
Sakakura N; Mori S; Okuda K; Fukui T; Hatooka S; Shinoda M; Matsuo K; Yatabe Y; Yokoi K; Mitsudomi T
Ann Thorac Surg; 2008 Oct; 86(4):1084-90. PubMed ID: 18805136
[TBL] [Abstract][Full Text] [Related]
28. Prognostic factors in resected stage I non-small cell lung cancer with a diameter of 3 cm or less: visceral pleural invasion did not influence overall and disease-free survival.
Hung JJ; Wang CY; Huang MH; Huang BS; Hsu WH; Wu YC
J Thorac Cardiovasc Surg; 2007 Sep; 134(3):638-43. PubMed ID: 17723811
[TBL] [Abstract][Full Text] [Related]
29. Clinicopathologic study of resected, peripheral, small-sized, non-small cell lung cancer tumors of 2 cm or less in diameter: pleural invasion and increase of serum carcinoembryonic antigen level as predictors of nodal involvement.
Inoue M; Minami M; Shiono H; Sawabata N; Ideguchi K; Okumura M
J Thorac Cardiovasc Surg; 2006 May; 131(5):988-93. PubMed ID: 16678580
[TBL] [Abstract][Full Text] [Related]
30. Hepatocyte growth factor and invasion-stimulatory activity are induced in pleural fluid by surgery in lung cancer patients.
Uchiyama A; Morisaki T; Beppu K; Kojima M; Matsunari Y; Nakatsuka A; Mizumoto K; Matsumoto K; Nakamura T; Tanaka M
Br J Cancer; 1999 Oct; 81(4):721-6. PubMed ID: 10574262
[TBL] [Abstract][Full Text] [Related]
31. A pilot clinical trial of vaccination with dendritic cells pulsed with autologous tumor cells derived from malignant pleural effusion in patients with late-stage lung carcinoma.
Chang GC; Lan HC; Juang SH; Wu YC; Lee HC; Hung YM; Yang HY; Whang-Peng J; Liu KJ
Cancer; 2005 Feb; 103(4):763-71. PubMed ID: 15637694
[TBL] [Abstract][Full Text] [Related]
32. The pathogenesis of pleural plaques and pulmonary asbestosis: possibilities and impossibilities.
Hillerdal G
Eur J Respir Dis; 1980 Jun; 61(3):129-38. PubMed ID: 7002573
[TBL] [Abstract][Full Text] [Related]
33. Lysis of fresh human tumor cells by autologous peripheral blood lymphocytes and pleural effusion lymphocytes activated by OK432.
Uchida A; Micksche M
J Natl Cancer Inst; 1983 Oct; 71(4):673-80. PubMed ID: 6413742
[TBL] [Abstract][Full Text] [Related]
34. Lymphocyte-induced macrophage cytotoxicity. Production of specific macrophage arming factor by sensitized Lyt 1+2+ T-lymphocytes.
Pels E; De Weger RA; Den Otter W
Int Arch Allergy Appl Immunol; 1984; 74(2):140-6. PubMed ID: 6609130
[TBL] [Abstract][Full Text] [Related]
35. [The characteristic of lymphokine-activated killer cells induced from tumor draining lymph-node cell].
Meng YG; Fu CY; Wang YZ
Zhonghua Fu Chan Ke Za Zhi; 1994 Sep; 29(9):535-7, 574. PubMed ID: 7835130
[TBL] [Abstract][Full Text] [Related]
36. Regulatory role of humoral factors released by macrophages in rat lymphocyte reactivity in vitro. I. Influence of humoral factors released by sensitized peritoneal macrophages on normal lymphocyte reactivity.
Brajczewska-Fischer W; Ryzewska AG
Arch Immunol Ther Exp (Warsz); 1980; 28(1):19-26. PubMed ID: 6968190
[TBL] [Abstract][Full Text] [Related]
37. Macrophage activation for tumor cytotoxicity: induction of macrophage tumoricidal activity by lymphokines from EL-4, a continuous T cell line.
Meltzer MS; Benjamin WR; Farrar JJ
J Immunol; 1982 Dec; 129(6):2802-7. PubMed ID: 6982943
[TBL] [Abstract][Full Text] [Related]
38. Natural cytostatic cells have a broader range of antitumor activity than natural killer cells.
Kato M; Kawauchi H; Taniguchi K; Katsuki T; Nomoto K
J Clin Lab Immunol; 1985 Jan; 16(1):47-51. PubMed ID: 3872372
[TBL] [Abstract][Full Text] [Related]
39. [Effect of tumor size and site on the prognosis in patients subjected to surgery for peripheral cancer of the lung].
Drukin EI; Karaseva NA
Vopr Onkol; 1985; 31(4):33-6. PubMed ID: 4002667
[TBL] [Abstract][Full Text] [Related]
40. [Cytostatic activity of the peritoneal macrophage in patients with gastric cancer].
Abe Y
Fukuoka Igaku Zasshi; 1985 Oct; 76(10):489-99. PubMed ID: 4093121
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]